Literature DB >> 30654024

Review and analysis of grading scales for ocular surface staining.

Carolyn Begley1, Barbara Caffery2, Robin Chalmers3, Ping Situ4, Trefford Simpson5, J Daniel Nelson6.   

Abstract

Vital dye staining has been used for over a century to assess the severity of ocular surface disease. However, despite common usage, a universally accepted "gold standard" grading scale does not exist for corneal and conjunctival staining, which can impact the ability to diagnose and monitor ocular surface conditions such as dry eye. The Food and Drug Administration (FDA) and other international regulatory agencies rely on ocular surface staining as a primary endpoint for new drug approvals, so that absence of a "gold standard" scale may affect approval of new drug treatments. To begin to address this problem, we review existing, published grading scales in an integrated fashion, highlighting their differences and similarities to emphasize common themes and the methods and elements that are important in creating a standardized scale. Our goal is to aid the field in moving towards an accepted standardized grading scale for ocular surface staining that can be applied in clinic and research settings for a variety of ocular conditions.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Conjunctiva; Cornea; Eye; Fluorescein; Grade; Lissamine green; Rose bengal; Scale; Stain

Year:  2019        PMID: 30654024     DOI: 10.1016/j.jtos.2019.01.004

Source DB:  PubMed          Journal:  Ocul Surf        ISSN: 1542-0124            Impact factor:   5.033


  17 in total

1.  Risk Factors for Ocular Surface Disease in Tunisian Users of Preserved Antiglaucomatous Eye Drops.

Authors:  Houda Lajmi; Wassim Hmaied; Besma Ben Achour; Amin Zahaf
Journal:  J Curr Ophthalmol       Date:  2021-07-05

2.  Vision-specific and cancer-specific quality of life in ocular graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Authors:  Yinglin Liao; Wenxin Zhao; Jing Yang; Shaowen Wu; Ling Jin; Fen Huang; Lingyi Liang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-08-27       Impact factor: 3.535

3.  Does the conjunctivochalasis accompanied by pseudoexfoliation syndrome affect the ocular surface and anterior segment structures?

Authors:  Bediz Özen; Hakan Öztürk
Journal:  Int Ophthalmol       Date:  2022-03-30       Impact factor: 2.029

4.  Impact of Improper Approach to Identify Lid Wiper Epitheliopathy (LWE).

Authors:  Christopher W Lievens; Yvonne Norgett; Nancy Briggs; Peter M Allen; Marta Vianya-Estopa
Journal:  Clin Ophthalmol       Date:  2020-10-06

Review 5.  Alternative therapies for dry eye disease.

Authors:  Rhiya Mittal; Sneh Patel; Anat Galor
Journal:  Curr Opin Ophthalmol       Date:  2021-07-01       Impact factor: 4.299

6.  Awareness of treatment: A source of bias in subjective grading of ocular complications.

Authors:  Genis Cardona; Noelia Esterich
Journal:  PLoS One       Date:  2019-12-26       Impact factor: 3.240

7.  A Prospective, Post-Market, Multicenter Trial (CHEETAH) Suggested TearCare® System as a Safe and Effective Blink-Assisted Eyelid Device for the Treatment of Dry Eye Disease.

Authors:  Paul Karpecki; David Wirta; Smajo Osmanovic; Kavita Dhamdhere
Journal:  Clin Ophthalmol       Date:  2020-12-30

8.  Efficacy and Safety of Preservative-free Latanoprost Eyedrops Compared with Preserved Prostaglandin Analogues in Patients with Open-angle Glaucoma.

Authors:  Hyo Jin Seong; Kwanghyun Lee; Seung Jae Lee; Sangah Kim; Jong Woon Park
Journal:  Korean J Ophthalmol       Date:  2021-06-04

Review 9.  Confocal Microscopy and Anterior Segment Optical Coherence Tomography Imaging of the Ocular Surface and Bleb Morphology in Medically and Surgically Treated Glaucoma Patients: A Review.

Authors:  Carmela Carnevale; Ivano Riva; Gloria Roberti; Manuele Michelessi; Lucia Tanga; Alice C Verticchio Vercellin; Luca Agnifili; Gianluca Manni; Alon Harris; Luciano Quaranta; Francesco Oddone
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-18

10.  Comparison of ocular surface assessment and adherence between preserved and preservative-free latanoprost in glaucoma: a parallel-grouped randomized trial.

Authors:  Dai Woo Kim; Jonghoon Shin; Chang Kyu Lee; Myungjin Kim; Sohyeon Lee; Seungsoo Rho
Journal:  Sci Rep       Date:  2021-07-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.